| scholarly article | Q13442814 |
| P50 | author | Young Hyo Kim | Q57142441 |
| P2093 | author name string | Tsuguhisa Nakayama | |
| Jayakar Nayak | |||
| P2860 | cites work | The plasticity and stability of regulatory T cells | Q50987847 |
| Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation | Q52545197 | ||
| A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease | Q73309096 | ||
| Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial | Q87550464 | ||
| N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis | Q22248070 | ||
| Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse | Q24290693 | ||
| Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria | Q24595940 | ||
| Posttranscriptional control of T cell effector function by aerobic glycolysis | Q24606942 | ||
| Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease | Q24630093 | ||
| Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy | Q24646296 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression | Q28272474 | ||
| The cancer cell's "power plants" as promising therapeutic targets: an overview | Q28296259 | ||
| Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation | Q28510102 | ||
| THE METABOLISM OF TUMORS IN THE BODY | Q29616202 | ||
| Glucosamine has an antiallergic effect in mice with allergic asthma and rhinitis | Q30101087 | ||
| Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. | Q30365133 | ||
| Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation | Q32058522 | ||
| Complementary medicine for the allergist. | Q32066734 | ||
| EBV gene expression in an NPC-related tumour. | Q33576708 | ||
| Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol | Q33691999 | ||
| Ndfip1 restricts mTORC1 signalling and glycolysis in regulatory T cells to prevent autoinflammatory disease | Q33780993 | ||
| Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc | Q33939701 | ||
| Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression | Q34136997 | ||
| Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2 | Q34180241 | ||
| Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. | Q34355664 | ||
| Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification | Q35019401 | ||
| HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells | Q35102340 | ||
| Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. | Q35404457 | ||
| O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress | Q35828212 | ||
| Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. | Q35897181 | ||
| Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. | Q36054460 | ||
| T(reg) stability: to be or not to be. | Q36711920 | ||
| Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast-like Synoviocytes | Q37131464 | ||
| The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R. | Q37358055 | ||
| Metabolism, cell surface organization, and disease | Q37671886 | ||
| Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2. | Q37713441 | ||
| 3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy | Q37737343 | ||
| The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC) | Q37976235 | ||
| Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting | Q38069803 | ||
| Tumor glycolysis as a target for cancer therapy: progress and prospects | Q38168262 | ||
| A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism | Q38710064 | ||
| A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. | Q39332797 | ||
| Anti-allergic activity of crystallinity controlled N-acetyl glucosamine | Q39349980 | ||
| Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. | Q40024031 | ||
| Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation | Q40048066 | ||
| LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma. | Q40113219 | ||
| Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. | Q40147884 | ||
| Protein O-GlcNAcylation: A critical regulator of the cellular response to stress. | Q40794510 | ||
| Asthma exacerbation associated with glucosamine-chondroitin supplement. | Q44236833 | ||
| Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions | Q44647527 | ||
| 2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition | Q44828921 | ||
| Pharmacokinetics and toxicity of oral and intravenous lonidamine in dogs | Q44866329 | ||
| Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells | Q44892424 | ||
| Is glucosamine safe in patients with seafood allergy? | Q45039591 | ||
| Oligomeric Procyanidins Interfere with Glycolysis of Activated T Cells. A Novel Mechanism for Inhibition of T Cell Function | Q46650261 | ||
| Control of T Cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis | Q46736652 | ||
| Augmented O-GlcNAc signaling via glucosamine attenuates oxidative stress and apoptosis following contrast-induced acute kidney injury in rats. | Q48888720 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 6-11 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Allergy, Asthma & Immunology Research | Q13429052 |
| P1476 | title | Glycolysis and the Hexosamine Biosynthetic Pathway as Novel Targets for Upper and Lower Airway Inflammation | |
| P478 | volume | 10 |
| Q91997323 | Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome | cites work | P2860 |
Search more.